“In a Prospective, Multicenter Study, the 31-GEP Identified Patients at Increased Risk of Tumor Recurrence and Added Significant Prognostic Value to AJCC Staging”. 2024. SKIN The Journal of Cutaneous Medicine 8 (6): s504. https://doi.org/10.25251/skin.8.supp.504.